Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing docetaxel plus S-1 versus S-1 alone for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)
  • S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Japan Clinical Cancer Research Organization | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED